New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia
Go back to New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia| Asianada, Inc. (NASDAQ: ASND) | Delayed: 228.00 -2.83 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.83 | 52 Week High | $21.79 | |||
| Open | $233.00 | 52 Week Low | $11.92 | |||
| Day High | $236.90 | P/E | N/A | |||
| Day Low | $227.13 | EPS | $-0.07 | |||
| Volume | 560,738 | |||||
